Artificial Intelligence and MRI Characterization of Tumors (Volume II)

Dear Colleagues,

This Special Issue is the second edition of “Artificial Intelligence and MRI Characterization of Tumors”, available at https://www.mdpi.com/journal/cancers/special_issues/AIAMCOT.

Cancer diagnosis and management remain complex and frequently require a multi-imaging assessment that allows for the staging of local and systemic disease. MRI is a highly accurate technique for the diagnosis and assessment of local disease extension, while CT, 18F-FDG PET/CT, and scintigraphy are often used for the confirmation of lymph node and systemic localization. Other laboratory, genetic, and histological parameters are essential to aid diagnosis, stratify risk, predict prognosis, and monitor patients during follow-up. However, many of these tools are susceptible to significant subjectivity.

In recent years, imaging-based machine learning processes, referred to as artificial intelligence, have been employed in many oncological fields, with promising results that aid in the support of medical decisions. This kind of analysis allows the extraction of many quantitative characteristics from medical images, called “features”, providing physicians with a valid decision-making tool. Using artificial intelligence algorithms reduces the degree of subjectivity and utilizes fewer resources to improve the overall efficiency and accuracy of cancer diagnosis and management.

In this Special Issue, we intend to enclose a current and important chapter on the role of artificial intelligence applied to various types of imaging modalities, in all phases of cancer evaluation, from diagnosis to therapy to prognosis. Both types of traditional machine learning approaches will be examined: radionics analysis and convolutional neural networks.

Dr. Eliodoro Faiella
Dr. Paolo Soda
Dr. Domiziana Santucci
Dr. Ermanno Cordelli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cancer
• MRI
• CT
• PET 18F-FDG
• PET/CT scintigraphy
• artificial intelligence (AI)
• radiomics convolutional neural networks (CNN)